145 related articles for article (PubMed ID: 24223628)
1. Inhibition of fibrosis and inflammation by triple therapy with pirfenidone, edaravone and erythropoietin in rabbits with drug-induced lung injury: comparison of CT imaging and pathological findings.
Watanabe S; Nitta N; Sonoda A; Nitta-Seko A; Ohta S; Tsuchiya K; Otani H; Tomozawa Y; Nagatani Y; Mukaisho K; Takahashi M; Murata K
Exp Ther Med; 2013 Nov; 6(5):1096-1100. PubMed ID: 24223628
[TBL] [Abstract][Full Text] [Related]
2. Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis.
Inomata M; Kamio K; Azuma A; Matsuda K; Kokuho N; Miura Y; Hayashi H; Nei T; Fujita K; Saito Y; Gemma A
Respir Res; 2014 Feb; 15(1):16. PubMed ID: 24507087
[TBL] [Abstract][Full Text] [Related]
3. The specific free radical scavenger edaravone suppresses bleomycin-induced acute pulmonary injury in rabbits.
Asai T; Ohno Y; Minatoguchi S; Funaguchi N; Yuhgetsu H; Sawada M; Takemura G; Komada A; Fujiwara T; Fujiwara H
Clin Exp Pharmacol Physiol; 2007; 34(1-2):22-6. PubMed ID: 17201731
[TBL] [Abstract][Full Text] [Related]
4. Effects of lecithinized superoxide dismutase and/or pirfenidone against bleomycin-induced pulmonary fibrosis.
Tanaka KI; Azuma A; Miyazaki Y; Sato K; Mizushima T
Chest; 2012 Oct; 142(4):1011-1019. PubMed ID: 22459774
[TBL] [Abstract][Full Text] [Related]
5. Pirfenidone suppresses bleomycin-induced pulmonary fibrosis and periostin expression in rats.
Song X; Yu W; Guo F
Exp Ther Med; 2018 Sep; 16(3):1800-1806. PubMed ID: 30186404
[TBL] [Abstract][Full Text] [Related]
6. Low dose pirfenidone suppresses transforming growth factor beta-1 and tissue inhibitor of metalloproteinase-1, and protects rats from lung fibrosis induced by bleomycina.
Tian XL; Yao W; Guo ZJ; Gu L; Zhu YJ
Chin Med Sci J; 2006 Sep; 21(3):145-51. PubMed ID: 17086734
[TBL] [Abstract][Full Text] [Related]
7. Asialoerythropoietin ameliorates bleomycin-induced acute lung injury in rabbits by reducing inflammation.
Sonoda A; Nitta N; Tsuchiya K; Otani H; Watanabe S; Mukaisho K; Tomozawa Y; Nagatani Y; Ohta S; Takahashi M; Murata K
Exp Ther Med; 2014 Nov; 8(5):1443-1446. PubMed ID: 25289037
[TBL] [Abstract][Full Text] [Related]
8. Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma.
Sakamoto K; Ito S; Hashimoto N; Hasegawa Y
BMC Cancer; 2017 Aug; 17(1):526. PubMed ID: 28784103
[TBL] [Abstract][Full Text] [Related]
9. Local delivery of biodegradable pirfenidone nanoparticles ameliorates bleomycin-induced pulmonary fibrosis in mice.
Trivedi R; Redente EF; Thakur A; Riches DW; Kompella UB
Nanotechnology; 2012 Dec; 23(50):505101. PubMed ID: 23186914
[TBL] [Abstract][Full Text] [Related]
10. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A
Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of pirfenidone on acute pulmonary injury and ensuing fibrosis in the hamster model of amiodarone-induced pulmonary toxicity.
Card JW; Racz WJ; Brien JF; Margolin SB; Massey TE
Toxicol Sci; 2003 Sep; 75(1):169-80. PubMed ID: 12832656
[TBL] [Abstract][Full Text] [Related]
12. Pirfenidone diminishes cyclophosphamide-induced lung fibrosis in mice.
Kehrer JP; Margolin SB
Toxicol Lett; 1997 Feb; 90(2-3):125-32. PubMed ID: 9067480
[TBL] [Abstract][Full Text] [Related]
13. Absence of early metabolic response assessed by 18F-FDG PET/CT after initiation of antifibrotic drugs in IPF patients.
Bondue B; Castiaux A; Van Simaeys G; Mathey C; Sherer F; Egrise D; Lacroix S; Huaux F; Doumont G; Goldman S
Respir Res; 2019 Jan; 20(1):10. PubMed ID: 30646908
[TBL] [Abstract][Full Text] [Related]
14. Pirfenidone activates cannabinoid receptor 2 in a mouse model of bleomycin-induced pulmonary fibrosis.
Liu J; Shi G
Exp Ther Med; 2019 Dec; 18(6):4241-4248. PubMed ID: 31777533
[TBL] [Abstract][Full Text] [Related]
15. Correlation between high resolution computed tomography and tissue morphometry of the lung in bleomycin-induced pulmonary fibrosis in the rabbit.
Hirose N; Lynch DA; Cherniack RM; Doherty DE
Am Rev Respir Dis; 1993 Mar; 147(3):730-8. PubMed ID: 7680190
[TBL] [Abstract][Full Text] [Related]
16. Comparison of reversal of rat pulmonary fibrosis of nintedanib, pirfenidone, and human umbilical mesenchymal stem cells from Wharton's jelly.
Chu KA; Yeh CC; Kuo FH; Lin WR; Hsu CW; Chen TH; Fu YS
Stem Cell Res Ther; 2020 Nov; 11(1):513. PubMed ID: 33256831
[TBL] [Abstract][Full Text] [Related]
17. Pirfenidone attenuates expression of HSP47 in murine bleomycin-induced pulmonary fibrosis.
Kakugawa T; Mukae H; Hayashi T; Ishii H; Abe K; Fujii T; Oku H; Miyazaki M; Kadota J; Kohno S
Eur Respir J; 2004 Jul; 24(1):57-65. PubMed ID: 15293605
[TBL] [Abstract][Full Text] [Related]
18. Combined prednisolone and pirfenidone in bleomycin-induced lung disease.
Vaidya PJ; Sandeepa HS; Singh T; Susheel Kumar SK; Bhargava R; Ramakrishnan G; Chhajed PN
J Cancer Res Ther; 2016; 12(3):1198-1202. PubMed ID: 28054535
[TBL] [Abstract][Full Text] [Related]
19. Does the concomitant intra-arterial injection of asialoerythropoietin and edaravone mitigate ischaemic mucosal damage after acute superior mesenteric artery thromboembolism in a rabbit autologous fibrin clot model?
Sonoda A; Nitta N; Seko A; Ohta S; Takemura S; Sugimoto T; Uzu T; Yokomaku Y; Takahashi M; Kashiwagi A; Murata K
Br J Radiol; 2010 Feb; 83(986):129-32. PubMed ID: 19546178
[TBL] [Abstract][Full Text] [Related]
20. Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models.
Yu W; Guo F; Song X
Pharm Biol; 2017 Dec; 55(1):450-455. PubMed ID: 27937011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
